% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Goldbrunner:849537,
author = {Goldbrunner, Roland and Ruge, Maximilian and Kocher, Martin
and Lucas, Carolin Weiß and Galldiks, Norbert and Grau,
Stefan},
title = {{T}he treatment of gliomas in adulthood},
journal = {Deutsches Ärzteblatt international},
volume = {115},
number = {20-21},
issn = {1866-0452},
address = {Köln},
publisher = {Dt. Ärzte-Verl.},
reportid = {FZJ-2018-03720},
pages = {356-364},
year = {2018},
abstract = {Background: Gliomas are the most common intrinsic tumors of
the brain, with an incidence of 6 per 100 000 persons per
year. Recent years have seen marked changes in the diagnosis
and treatment of gliomas, with molecular parameters now
being an integral part of the diagnostic evaluation.Methods:
This review is based on pertinent articles retrieved by a
selective search in PubMed, with special attention to the
new WHO glioma classification.Results: The classification of
gliomas on the basis of additional molecular parameters
enables more accurate prognostication and serves as a basis
for therapeutic decision-making and treatment according to
precisely specified algorithms. PET scanning with
18F-fluoroethyl tyrosine and 11C-methionine for the
measurement of metabolic activity in gliomas has further
refined the diagnostic evaluation. The median overall
survival of patients with glioblastoma who have undergone
resection of all tumor tissue with a disrupted blood–brain
barrier (i.e., all contrast-enhancing tumor tissue) has been
prolonged to up to 20 months. The 5-year survival of
patients with WHO grade II gliomas is now as high as $97\%$
after near-total resection. The surgical resection of all
contrast-enhancing tumor tissue and subsequent radiotherapy
and chemotherapy remain the key elements of treatment. New
surgical strategies and new methods of planning radiotherapy
have made these techniques safer and more effective. The
percutaneous application of tumor-treating fields is a new
therapeutic option that has gained a degree of acceptance.
Accompanying measures such as psycho-oncology and palliative
care are very important for patients and should be
considered mandatory.Conclusion: The consistent application
of the existing multimodal treatment options for glioma has
led in recent years to improved survival. Areas of important
current and future scientific activity include immunotherapy
and targeted and combined chemotherapy, as well as altered
neurocognition, modern approaches to palliative care, and
complementary therapies.},
cin = {INM-3},
ddc = {610},
cid = {I:(DE-Juel1)INM-3-20090406},
pnm = {572 - (Dys-)function and Plasticity (POF3-572)},
pid = {G:(DE-HGF)POF3-572},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:29914619},
UT = {WOS:000435360200008},
doi = {10.3238/arztebl.2018.0356},
url = {https://juser.fz-juelich.de/record/849537},
}